The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.

doi:10.1093/rheumatology/keab152

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.

Rheumatology (Oxford, England) - 3 Nov 2021

Lazzaroni Maria-Grazia, Marasco Emiliano, Campochiaro Corrado, DeVries-Bouwstra Jeska, Gonzalez-Perez Montserrat-Ixchel, Rojas-Serrano Jorge, Hachulla Eric, Zanatta Elisabetta, Barsotti Simone, Furini Federica, Triantafyllias Konstantinos, Abignano Giuseppina, Truchetet Marie-Elise, De Luca Giacomo, De Langhe Ellen, Hesselstrand Roger, Ingegnoli Francesca, Bertoldo Eugenia, Smith Vanessa, Bellando-Randone Silvia, Poormoghim Hadi, Colombo Enrico, Ceribelli Angela, Furloni Alessio, Zingarelli Stefania, Cavazzana Ilaria, Franceschini Franco, Del Galdo Francesco, Denton Christopher P, Cavagna Lorenzo, Distler Oliver, Allanore Yannick, Airò Paolo

Abstract excerpt

OBJECTIVE: To evaluate clinical associations of anti-PM/Scl antibodies in patients with SSc in a multicentre international cohort, with particular focus on unresolved issues, including scleroderma renal crisis (RC), malignancies, and functional outcome of interstitial lung disease (ILD). METHODS: (1) Analysis of SSc patients from the EUSTAR database: 144 anti-PM/Scl+ without SSc-specific autoantibodies were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoantibodies

Share to Europe

Share to Exoribonucleases

Share to Exosome Multienzyme Ribonuclease Complex

Share to Phenotype

Share to Registries

Share to Scleroderma, Systemic

Source

Open in PubMed

Identifiers

PMID: 33580257
DOI: 10.1093/rheumatology/keab152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.PMID 33580257Read ↗

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.Semantic proximity Read ↗

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.Semantic proximity Read ↗

Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.Semantic proximity Read ↗

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.Semantic proximity Read ↗

Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.Semantic proximity Read ↗

Clinico-pathological phenotypes of systemic sclerosis-associated myopathy: analysis of a large multicentre cohort.Semantic proximity Read ↗

Treatable Traits in Systemic Sclerosis.Semantic proximity Read ↗

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.Semantic proximity Read ↗

Clinical Phenotypes of Patients With Systemic Sclerosis With Distinct Molecular Signatures in Skin.Semantic proximity Read ↗

Systemic sclerosis.Semantic proximity Read ↗

Objective gastrointestinal involvement in patients with systemic sclerosis: Prevalence and clinico-immunological phenotypes in the REMSCLE registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.